Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-28 @ 11:06 AM
Study NCT ID:
NCT00081159
Status:
COMPLETED
Last Update Posted:
2016-11-10
First Post:
2004-04-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09
Completion Date Type:
ACTUAL
First Submit Date:
2004-04-07
First Submit QC Date:
None
Study First Post Date:
2004-04-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-22
Results First Submit QC Date:
None
Results First Post Date:
2016-11-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-22
Last Update Post Date:
2016-11-10
Last Update Post Date Type:
ESTIMATED